Crystal form of sodium (5-(4-bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-yl)(sulfamoyl)amide
JP2025517798APending Publication Date: 2025-06-10IDORSIA PHARMACEUTICALS LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- JP2024569342
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-05-25
- Filing Date
- 2023-05-25
- Publication Date
- 2025-06-10
Abstract
The present invention relates to a novel crystalline form of aprocitentan sodium salt, a method for producing the same, a pharmaceutical composition having the crystalline form, a pharmaceutical composition produced from such a crystalline form, and their use as endothelin receptor antagonists.
Need to check novelty before this filing date? Find Prior Art